Long Run Wealth Advisors LLC Buys Shares of 355 UnitedHealth Group Incorporated (NYSE:UNH)

Long Run Wealth Advisors LLC acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNHFree Report) during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 355 shares of the healthcare conglomerate’s stock, valued at approximately $208,000.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. HMS Capital Management LLC increased its holdings in UnitedHealth Group by 6.5% in the third quarter. HMS Capital Management LLC now owns 3,691 shares of the healthcare conglomerate’s stock valued at $2,158,000 after purchasing an additional 224 shares during the last quarter. Focused Wealth Management Inc raised its position in shares of UnitedHealth Group by 9.5% in the 3rd quarter. Focused Wealth Management Inc now owns 577 shares of the healthcare conglomerate’s stock valued at $337,000 after acquiring an additional 50 shares during the period. Fiduciary Family Office LLC grew its holdings in UnitedHealth Group by 26.3% during the third quarter. Fiduciary Family Office LLC now owns 3,806 shares of the healthcare conglomerate’s stock valued at $2,225,000 after purchasing an additional 792 shares during the period. Cornerstone Capital Inc. raised its holdings in UnitedHealth Group by 4.0% in the third quarter. Cornerstone Capital Inc. now owns 1,092 shares of the healthcare conglomerate’s stock worth $638,000 after purchasing an additional 42 shares during the period. Finally, Falcon Wealth Planning acquired a new position in shares of UnitedHealth Group in the 3rd quarter valued at $207,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

NYSE:UNH opened at $566.96 on Wednesday. The company has a quick ratio of 0.88, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a market capitalization of $523.54 billion, a price-to-earnings ratio of 36.94, a P/E/G ratio of 1.64 and a beta of 0.58. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $608.63. The stock’s 50 day moving average price is $580.96 and its two-hundred day moving average price is $543.36.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The company had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. UnitedHealth Group’s quarterly revenue was up 9.2% compared to the same quarter last year. During the same quarter last year, the company posted $6.56 EPS. On average, analysts anticipate that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.48%. UnitedHealth Group’s dividend payout ratio is 54.72%.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the company. HSBC lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 17th. Hsbc Global Res cut UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 17th. Jefferies Financial Group raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and upped their target price for the stock from $481.00 to $647.00 in a research note on Wednesday, July 17th. Royal Bank of Canada cut their price target on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a report on Wednesday, October 16th. Finally, Argus lifted their target price on UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. Four investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $615.53.

Read Our Latest Report on UnitedHealth Group

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.